Editorial
Published on 01 Jun 2023
Editorial: Circulating tumor DNA in cancer: a role as a response and monitoring “next-generation” biomarker in cancer therapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1210866
Type at least 3 characters
23,565 articles
Articles
Case Report
Accepted on 31 May 2023
Case Report: An exceptional response to neoadjuvant therapy in undifferentiated pleomorphic sarcoma following checkpoint inhibitor use
Frontiers in Oncology
doi 10.3389/fonc.2023.1198292
Review
Accepted on 31 May 2023
Altered expression of AXL receptor tyrosine kinase in gastrointestinal cancers: a promising therapeutic target
Frontiers in Oncology
doi 10.3389/fonc.2023.1079041
Editorial
Accepted on 31 May 2023
Editorial: Novel Targeted Drugs for Indolent Lymphoid Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1224528
Original Research
Accepted on 31 May 2023
Potential Risk of Tamoxifen: Gut Microbiota and Inflammation in Mice with Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1121471
Editorial
Accepted on 31 May 2023
Editorial: Immunometabolism and Therapeutic Targeting of Aggressive Cancers
Frontiers in Oncology
doi 10.3389/fonc.2023.1226078
Original Research
Accepted on 31 May 2023
Bioinformatic-based Genetic Characterizations of Neural Regulation in Skin Cutaneous Melanoma
Frontiers in Oncology
doi 10.3389/fonc.2023.1166373
Original Research
Accepted on 31 May 2023
Risk Factors and A New Nomogram for Predicting Lung Cancer Patients with Brain Metastases：A Retrospective Study
Frontiers in Oncology
doi 10.3389/fonc.2023.1092721
Original Research
Accepted on 31 May 2023
Rac and Cdc42 inhibitors reduce macrophage function in breast cancer preclinical models
Frontiers in Oncology
doi 10.3389/fonc.2023.1152458
Review
Accepted on 31 May 2023
Clinical diagnostic biomarker "circulating tumor cells" in breast cancer - a meta-analysis
Frontiers in Oncology
doi 10.3389/fonc.2023.1137519
Original Research
Accepted on 31 May 2023
Integration Analysis of Single-cell and Spatial transcriptomics reveal the Cellular Heterogeneity Landscape in Glioblastoma and establish a Polygenic Risk Model
Frontiers in Oncology
doi 10.3389/fonc.2023.1109037
Case Report
Accepted on 31 May 2023
Case Report: Irinotecan-Induced Interstitial Lung Disease in an Advanced Colorectal Cancer Patient Resurfacing Decades After Allogeneic Bone Marrow Transplantation for Aplastic Anemia; A Case Report and Narrative Review of Literature
Frontiers in Oncology
doi 10.3389/fonc.2023.1215789
Original Research
Accepted on 31 May 2023
Dose outside of the prostate is associated with improved outcomes for high-risk prostate cancer patients treated with Brachytherapy Boost
Frontiers in Oncology
doi 10.3389/fonc.2023.1200676
Mini Review
Accepted on 31 May 2023
The role of EBV-encoded miRNA in EBV-associated gastric cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1204030
Systematic Review
Accepted on 31 May 2023
Efficacy and safety of histone deacetylase inhibitors in peripheral T-cell lymphoma: a systematic review and meta-analysis on prospective clinical trials
Frontiers in Oncology
doi 10.3389/fonc.2023.1127112
Original Research
Accepted on 31 May 2023
Real-world data of pyrotinib-based therapy for patients with brain metastases of HER2-positive advanced breast cancer: a single-center retrospective analysis and molecular portraits
Frontiers in Oncology
doi 10.3389/fonc.2023.1105474